Parenchymal-sparing hepatectomy for multiple bilobar colorectal liver metastases in a Jehovah's witness: a case report.
Shehan RatnayakeDuminda SubasingheVihara DassanayakeSivasuriya SivaganeshPublished in: Journal of liver cancer (2023)
Parenchymal-sparing hepatectomy (PSH), though technically challenging, is emerging as a choice of treatment for colorectal liver metastases (CRLM). PSH in Jehovah's witness (JW) patients, for whom transfusion is not an option, involves complex surgical and medicolegal issues. A 52-year-old JW male with synchronous, multiple, bilobar liver metastases from a rectal adenocarcinoma was referred following neoadjuvant chemotherapy. At surgery, 10 metastatic deposits were observed and confirmed by intraoperative ultrasonography. Parenchymal-sparing non-anatomical resections were performed using a cavitron ultrasonic aspirator with the application of intermittent Pringle maneuvres. Histology confirmed multiple CRLMs with tumor-free resection margins. PSH is increasingly employed for CRLMs to preserve residual liver volume and minimize morbidity without compromising oncological outcomes. It is technically challenging, especially in the presence of bilobar, multi-segmental disease. This case illustrates the feasibility of performing complex hepatic surgery in special patient groups by meticulous planning and preparation involving multiple specialties and the patient.
Keyphrases
- liver metastases
- neoadjuvant chemotherapy
- robot assisted
- minimally invasive
- locally advanced
- end stage renal disease
- squamous cell carcinoma
- coronary artery bypass
- case report
- rectal cancer
- chronic kidney disease
- small cell lung cancer
- ejection fraction
- lymph node
- prognostic factors
- radiation therapy
- percutaneous coronary intervention
- sentinel lymph node
- metabolic syndrome
- patients undergoing
- adipose tissue
- early stage
- high resolution
- patient reported outcomes
- radical prostatectomy
- high intensity
- skeletal muscle